Implantica announces publication of a new health economics study showing RefluxStop®'s superior cost-effectiveness in the treatment of GERD in the Italian Healthcare System

Contributed by: PR Newswire

Tags

IMPLANTICA-study

More Like This

Implantica announces new health-economics data publication showing RefluxStop™'s superior cost-effectiveness for the Swiss healthcare system

Implantica's RefluxStop™ health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world's leading European Health-Economics Conference

Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results

Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal

Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany - presented at the AUGIS meeting in UK

Implantica announces major public tender wins in Italy securing over EUR 1.2 million funding for RefluxStop®

Implantica announces new exceptional published data from the largest real-world study from Germany

Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study